Management of intracerebral hemorrhage–use of statins

References

• FeiginVLLawesCMBennettDABarker-ColloSLParagVWorldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic reviewLancet Neurol2009835536919233729
   PubMed Web of Science ®Google Scholar
• van AschCJLuitseMJRinkelGJvan der TweelIAlgraAKlijnCJIncidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysisLancet Neurol2010916717620056489
   PubMed Web of Science ®Google Scholar
• QureshiAITuhrimSBroderickJPBatjerHHHondoHHanleyDFSpontaneous intracerebral hemorrhageN Engl J Med20013441450146011346811
   PubMed Web of Science ®Google Scholar
• AriesenMJClausSPRinkelGJAlgraARisk factors for intracerebral hemorrhage in the general population: a systematic reviewStroke2003342060206512843354
   PubMed Web of Science ®Google Scholar
• BrustJCClinical, radiological, and pathological aspects of cerebrovascular disease associated with drug abuseStroke199324I129I1338249009
   PubMed Web of Science ®Google Scholar
• SiniscalchiABonciAMercuriNBCocaine dependence and stroke: pathogenesis and managementCurr Neurovasc Res20151216317225742568
   PubMed Web of Science ®Google Scholar
• PoonMTFonvilleAFAl-Shahi SalmanRLong-term prognosis after intracerebral haemorrhage: systematic review and meta-analysisJ Neurol Psychiatry201485660667
   PubMed Web of Science ®Google Scholar
• SchachterMChemical, pharmacokinetic and pharmacodynamic properties of statins: an updateFundamental Clin Pharmacol200519117125
   PubMed Web of Science ®Google Scholar
• McFarlandAJAnoopkumar-DukieSAroraDSMolecular mechanisms underlying the effects of statins in the central nervous systemInt J Mol Sci201415206072063725391045
   PubMed Web of Science ®Google Scholar
• TaylorFHuffmanMDMacedoAFStatins for the primary prevention of cardiovascular diseaseCochrane Database Syst Rev20131CD00481623440795
   PubMed Web of Science ®Google Scholar
• WilleyJZElkindMS3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the treatment of central nervous system diseasesArch Neurol2010671062106720837848
   PubMedGoogle Scholar
• MihosCGPinedaAMSantanaOCardiovascular effects of statins, beyond lipid-lowering propertiesPharmacol Res201488121924631782
   PubMed Web of Science ®Google Scholar
• CorsiniABellostaSBaettaRFumagalliRPaolettiRBerniniFNew insights into the pharmacodynamic and pharmacokinetic properties of statinsPharmacol Ther19998441342810665838
   PubMed Web of Science ®Google Scholar
• WoodWGEckertGPIgbavboaUMullerWEStatins and neuroprotection: a prescription to move the field forwardAnn N Y Acad Sci20101199697620633110
   PubMed Web of Science ®Google Scholar
• Johnson-AnunaLNEckertGPKellerJHChronic administration of statins alters multiple gene expression patterns in mouse cerebral cortexJ Pharmacol Exp Ther200531278679315358814
   PubMed Web of Science ®Google Scholar
• ThelenKMRentschKMGutteckUBrain cholesterol synthesis in mice is affected by high dose of simvastatin but not of pravastatinJ Pharmacol Exp Ther20063161146115216282522
   PubMed Web of Science ®Google Scholar
• JonesPKafonekSLauroraIHunninghakeDComparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)Am J Cardiol1998815825879514454
   PubMed Web of Science ®Google Scholar
• JonesPHDavidsonMHSteinEAComparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial)Am J Cardiol20039215216012860216
   PubMed Web of Science ®Google Scholar
• BaysHStatin safety: an overview and assessment of the data–2005Am J Cardiol2006976c26c
   PubMed Web of Science ®Google Scholar
• KirkpatrickPJTurnerCLSmithCHutchinsonPJMurrayGDSTASH CollaboratorsSimvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trialLancet Neurol20141366667524837690
   PubMed Web of Science ®Google Scholar
• LatronicoNBoltonCFCritical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysisLancet Neurol20111093194121939902
   PubMed Web of Science ®Google Scholar
• PanditLAgrawalANeuromuscular disorders in critical illnessClin Neurol Neurosurg200610862162716730883
   PubMed Web of Science ®Google Scholar
• SchweickertWDHallJICU-acquired weaknessChest20071311541154917494803
   PubMed Web of Science ®Google Scholar
• GorsonKCApproach to neuromuscular disorders in the intensive care unitNeurocrit care2005319521216377830
   PubMed Web of Science ®Google Scholar
• BolegoCBaettaRBellostaSCorsiniAPaolettiRSafety considerations for statinsCurr Opin Lipidol20021363764412441888
   PubMed Web of Science ®Google Scholar
• AmarencoPBogousslavskyJCallahanA3rdThe Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) InvestigatorsHigh-dose atorvastatin after stroke or transient ischemic attackN Engl J Med200635554955916899775
   PubMed Web of Science ®Google Scholar
• GoldsteinLBAmarencoPZivinJStroke Prevention by Aggressive Reduction in Cholesterol Levels InvestigatorsStatin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trialStroke2009403526353119745172
   PubMed Web of Science ®Google Scholar
• AsbergSErikssonMStatin therapy and the risk of intracerebral haemorrhage: a nationwide observational studyInt J Stroke2015464926043664
   PubMed Web of Science ®Google Scholar
• DowlatshahiDDemchukAMFangJKapralMKSharmaMSmithEERegistry of the Canadian Stroke NetworkAssociation of statins and statin discontinuation with poor outcome and survival after intracerebral hemorrhageStroke2012431518152322442172
   PubMed Web of Science ®Google Scholar
• HackamDGWoodwardMNewbyLKStatins and intracerebral hemorrhage: collaborative systematic review and meta-analysisCirculation20111242233224222007076
   PubMed Web of Science ®Google Scholar
• JungJMChoiJYKimHJSeoWKStatin use in spontaneous intracerebral hemorrhage: a systematic review and meta-analysisInt J Stroke2015101726306674
   PubMed Web of Science ®Google Scholar
• Tapia PerezJHYildizOCSchneiderTNimskyCMeta-analysis of statin use for the acute therapy of spontaneous intracerebral hemorrhageJ Stroke Cerebrovasc Dis201524112521252626387046
   PubMed Web of Science ®Google Scholar
• McKinneyJSKostisWJStatin therapy and the risk of intracerebral hemorrhage: a meta-analysis of 31 randomized controlled trialsStroke2012432149215622588266
   PubMed Web of Science ®Google Scholar
• SteinerTAl-Shahi SalmanRBeerREuropean Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhageInt J Stroke2014984085525156220
   PubMed Web of Science ®Google Scholar
• FlintACConellCRaoVAEffect of statin use during hospitalization for intracerebral hemorrhage on mortality and discharge dispositionJAMA Neurol2014711364137125244578
   PubMed Web of Science ®Google Scholar
• WinklerJShoupJPCzapALong-term improvement in outcome after intracerebral hemorrhage in patients treated with statinsJ Stroke Cerebrovasc Dis201322e541e54523867041
   PubMed Web of Science ®Google Scholar
• ChenPSChengCLChangYCKao YangYHYehPSLiYHEarly statin therapy in patients with acute intracerebral hemorrhage without prior statin useEur J Neurol20152277378025623473
   PubMed Web of Science ®Google Scholar
• PanYSJingJWangYLUse of statin during hospitalization improves the outcome after intracerebral hemorrhageCNS Neurosci Ther20142054855524750990
   PubMed Web of Science ®Google Scholar
• UyttenboogaartMKochMWKoopmanKVroomenPCLuijckxGJDe KeyserJLipid profile, statin use, and outcome after intravenous thrombolysis for acute ischaemic strokeJ Neurol200825587588018338194
   PubMed Web of Science ®Google Scholar
• MiuraKYoshiiYNakamuraYIkedaKClinicoradiological profile and serum lipid levels of intracerebral hemorrhage in prior statin usersIntern Med2011501385139121720057
   PubMed Web of Science ®Google Scholar
• MustanojaSStrbianDPutaalaJAssociation of prestroke statin use and lipid levels with outcome of intracerebral hemorrhageStroke2013442330233223760210
   PubMed Web of Science ®Google Scholar
• GreenbergSMVernooijMWCordonnierCCerebral microbleeds: a guide to detection and interpretationLancet Neurol2009816517419161908
   PubMed Web of Science ®Google Scholar
• RomeroJRPreisSRBeiserARisk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart StudyStroke2014451492149424713533
   PubMed Web of Science ®Google Scholar
• van EttenESAurielEHaleyKEIncidence of symptomatic hemorrhage in patients with lobar microbleedsStroke2014452280228524947286
   PubMed Web of Science ®Google Scholar
• SooYOYangSRLamWWRisk vs benefit of anti-thrombotic therapy in ischaemic stroke patients with cerebral microbleedsJ Neurol20082551679168619156486
   PubMed Web of Science ®Google Scholar
• VernooijMWHaagMDvan der LugtAUse of antithrombotic drugs and the presence of cerebral microbleeds: the Rotterdam Scan StudyArch Neurol20096671472019364926
   PubMedGoogle Scholar
• LeeSHRyuWSRohJKCerebral microbleeds are a risk factor for warfarin-related intracerebral hemorrhageNeurology20097217117619139370
   PubMed Web of Science ®Google Scholar
• DannenbergSScheitzJFRozanskiMNumber of cerebral microbleeds and risk of intracerebral hemorrhage after intravenous thrombolysisStroke2014452900290525116882
   PubMed Web of Science ®Google Scholar
• SperlingRSallowaySBrooksDJAmyloid-related imaging abnormalities in patients with Alzheimer’s disease treated with bapineuzumab: a retrospective analysisLancet Neurol20121124124922305802
   PubMed Web of Science ®Google Scholar
• ArrighiHMBarakosJBarkhofFAmyloid-related imaging abnormalities-haemosiderin (ARIA-H) in patients with Alzheimer’s disease treated with bapineuzumab: a historical, prospective secondary analysisJ Neurol Neurosurg Psychiatry20168710611225669746
   PubMed Web of Science ®Google Scholar
• HaussenDCHenningerNKumarSSelimMStatin use and microbleeds in patients with spontaneous intracerebral hemorrhageStroke2012432677268122829545
   PubMed Web of Science ®Google Scholar
• LeeSHBaeHJYoonBWKimHKimDERohJKLow concentration of serum total cholesterol is associated with multifocal signal loss lesions on gradient-echo magnetic resonance imaging: analysis of risk factors for multifocal signal loss lesionsStroke2002332845284912468780
   PubMed Web of Science ®Google Scholar
• BangOYSaverJLLiebeskindDSCholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysisNeurology20076873774217182976
   PubMed Web of Science ®Google Scholar
• OrkenDNKenangilGUysalEGundogduLErginozEFortaHLack of association between cerebral microbleeds and low serum cholesterol in patients with acute intracerebral hemorrhageClin Neurol Neurosurg201011266867120627554
   PubMed Web of Science ®Google Scholar
• RomeroJRPreisSRBeiserASLipoprotein phospholipase A2 and cerebral microbleeds in the Framingham Heart StudyStroke2012433091309422961963
   PubMed Web of Science ®Google Scholar
• WooDDekaRFalconeGJApolipoprotein E, statins, and risk of intracerebral hemorrhageStroke2013443013301724008570
   PubMed Web of Science ®Google Scholar
• RidkerPMDanielsonEFonsecaFARosuvastatin to prevent vascular events in men and women with elevated C-reactive proteinN Engl J Med20083592195220718997196
   PubMed Web of Science ®Google Scholar
• HongKSLeeJSStatins in acute ischemic stroke: a systematic reviewJ Stroke20151728230126437994
   PubMed Web of Science ®Google Scholar
• Heart Protection Study Collaborative GroupMRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trialLancet200236072212114036
   PubMed Web of Science ®Google Scholar
• StoneNJRobinsonJGLichtensteinAH2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesCirculation2014129S1S4524222016
   PubMed Web of Science ®Google Scholar
• KernanWNOvbiageleBBlackHRGuidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke AssociationStroke2014452160223624788967
   PubMed Web of Science ®Google Scholar
• GoldsteinLBAmarencoPSzarekMHemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels studyNeurology2008702364237018077795
   PubMed Web of Science ®Google Scholar
• IsoHJacobsDRJrWentworthDNeatonJDCohenJDSerum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trialN Engl J Med19893209049102619783
   PubMed Web of Science ®Google Scholar
• KonishiMIsoHKomachiYAssociations of serum total cholesterol, different types of stroke, and stenosis distribution of cerebral arteriesStroke1993249549648322395
   PubMed Web of Science ®Google Scholar
• LaufsUGertzKHuangPAtorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic miceStroke2000312442244911022078
   PubMed Web of Science ®Google Scholar
• YokoyamaSIkedaHHaramakiNYasukawaHKatohAImaizumiTHMG-CoA reductase inhibitor protects against in vivo arterial thrombosis by augmenting platelet-derived nitric oxide release in ratsJ Cardiovasc Pharmacol20054537538115772528
   PubMed Web of Science ®Google Scholar
• AsahiMHuangZThomasSProtective effects of statins involving both eNOS and tPA in focal cerebral ischemiaJ Cereb Blood Flow Metab20052572272915716855
   PubMed Web of Science ®Google Scholar